Familial and attributable risks in cutaneous melanoma: effects of proband and age.
暂无分享,去创建一个
[1] H. Møller,et al. Second primary cancers in patients with squamous cell carcinoma of the skin , 2004, British Journal of Cancer.
[2] K. Czene,et al. Attributable risks of familial cancer from the Family-Cancer Database. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[3] K. Hemminki,et al. Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. , 2002, The American journal of pathology.
[4] Florence Demenais,et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.
[5] K. Hemminki,et al. Cancer risks among long-standing spouses , 2002, British Journal of Cancer.
[6] K. Czene,et al. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.
[7] K. Hemminki,et al. In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients , 2002, International journal of cancer.
[8] Maria Teresa Landi,et al. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. , 2002, Journal of the National Cancer Institute.
[9] U. Ringborg,et al. Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.
[10] K. Hemminki,et al. A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare , 2001, International journal of cancer.
[11] J. Bolognia,et al. The melanocortin-1 receptor: red hair and beyond. , 2001, Archives of dermatology.
[12] L. Sandkuijl,et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. , 2001, American journal of human genetics.
[13] K. Hemminki,et al. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. , 2001 .
[14] J. Peto,et al. Genetics and the common cancers. , 2001, European journal of cancer.
[15] M T Landi,et al. Combined risk factors for melanoma in a Mediterranean population , 2001, British Journal of Cancer.
[16] R. Willemze,et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.
[17] J. Barrett,et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.
[18] N. Risch,et al. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] V. P. Collins,et al. Parental Cancer as a Risk Factor for Brain Tumors (Sweden) , 2001, Cancer Causes & Control.
[20] K. Hemminki,et al. A population-based study of familial soft tissue tumors. , 2001, Journal of clinical epidemiology.
[21] K. Hemminki,et al. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families , 2001, International journal of cancer.
[22] K. Hemminki,et al. A population-based study of familial cutaneous melanoma , 2001, Melanoma research.
[23] K. Hemminki,et al. Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. , 2001, Journal of the National Cancer Institute.
[24] D. Easton,et al. Sibling risks in cancer: clues to recessive or X-linked genes? , 2001, British Journal of Cancer.
[25] K. Hemminki,et al. Cancer risks to spouses and offspring in the family‐cancer database , 2001, Genetic epidemiology.
[26] P Vineis,et al. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. , 2000, Journal of the National Cancer Institute.
[27] Å. Borg,et al. High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families , 2000 .
[28] J. Rees,et al. The melanocortin 1 receptor (MC1R): more than just red hair. , 2000, Pigment cell research.
[29] K. Hemminki,et al. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. , 2000, Archives of dermatology.
[30] K. Hemminki,et al. Cutaneous melanoma patients have normal repair kinetics of ultraviolet-induced DNA repair in skin in situ. , 2000, The Journal of investigative dermatology.
[31] P. Brennan,et al. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia , 2000, British Journal of Cancer.
[32] U. Ringborg,et al. Cancer risk in patients with earlier diagnosis of cutaneous melanoma In situ , 1999, International journal of cancer.
[33] M. Greene. The genetics of hereditary melanoma and nevi , 1999, Cancer.
[34] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.
[35] D. Duffy,et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.
[36] A. Burden,et al. Genetic and environmental influences in the development of multiple primary melanoma. , 1999, Archives of dermatology.
[37] U. Ringborg,et al. Second primary cancers in patients with squamous cell carcinoma of the skin: A population‐based study in Sweden , 1999, International journal of cancer.
[38] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[39] P. Kyyrönen,et al. Age‐specific familial risks in common cancers of the offspring , 1998, International journal of cancer.
[40] L. Fritschi,et al. Characteristics of familial and non-familial melanoma in Australia , 1998, Melanoma research.
[41] K. Hemminki,et al. Familial risks in in situ cancers from the Family-Cancer Database. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[42] R. Severson,et al. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma , 1998, Cancer.
[43] C. la Vecchia,et al. Incidence of invasive cancers following basal cell skin cancer. , 1998, American journal of epidemiology.
[44] E. Fearon. Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.
[45] D. Bishop,et al. Germline mutations of the CDKN2 gene in UK melanoma families. , 1997, Human molecular genetics.
[46] C. la Vecchia,et al. Incidence of invasive cancers following squamous cell skin cancer. , 1997, American journal of epidemiology.
[47] M. Inganäs,et al. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. , 1997, Journal of the National Cancer Institute.
[48] Bruce K. Armstrong,et al. Sunlight and cancer , 1997, Cancer Causes & Control.
[49] C. la Vecchia,et al. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. , 1996, British Journal of Cancer.
[50] R. MacKie,et al. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. , 1996, British Journal of Cancer.
[51] U. Ringborg,et al. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. , 1996, British Journal of Cancer.
[52] M. Tucker,et al. Genetic epidemiology of familial melanoma. , 1995, Dermatologic clinics.
[53] M. Melbye,et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.
[54] A. Swerdlow,et al. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in denmark, 1943–1989 , 1995, International journal of cancer.
[55] M. Melbye,et al. New primary cancers after squamous cell skin cancer. , 1995, American journal of epidemiology.
[56] M H Skolnick,et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.
[57] S. Wacholder,et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.
[58] B. Hankey,et al. Second cancers following non‐Hodgkin's lymphoma , 1991, Cancer.
[59] O S Miettinen,et al. Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.
[60] N. Risch,et al. Genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches Cancer Epidemiol. Biomark , 2002 .
[61] K. Hemminki,et al. Primary cancers following squamous cell carcinoma of the skin suggest involvement of Epstein-Barr virus. , 2000, Epidemiology.
[62] U. Ringborg,et al. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study. , 1999, Acta oncologica.
[63] H. Olsson. Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.
[64] K. Hemminki,et al. National database of familial cancer in Sweden , 1998, Genetic epidemiology.
[65] J. Aitken,et al. Segregation analysis of cutaneous melanoma in Queensland , 1998, Genetic epidemiology.
[66] J. Elwood,et al. Melanoma and ultraviolet radiation. , 1992, Clinics in dermatology.
[67] B. Macmahon,et al. Epidemiology: Principles and Methods , 1970 .